Mental Health Clinics in Leechburg, PA Accepting Medicare
6 Mental Health Clinics found. Showing 1 - 6
 Explicit Empathy Counseling Services Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 152 Market St, Leechburg, PA 15656 Phone: 412-612-2799 |
Balance And Grow Counseling Center Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 152 Market St, Leechburg, PA 15656 Phone: 724-787-9090 |
Family Counseling Center Of Armstrong County Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 321 State Route 66, Leechburg, PA 15656 Phone: 724-845-6667 Fax: 724-845-2533 |
Arc Manor Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 116 Main St, Leechburg, PA 15656 Phone: 724-845-7265 |
Camp Unity Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 1001 S Leechburg Hill Rd, Leechburg, PA 15656 Phone: 724-845-2978 Fax: 724-845-0923 |
Family Counseling Center Of Armstrong County Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 321 Route 66, Leechburg, PA 15656 Phone: 724-845-6755 Fax: 724-845-6150 |
News Archive
CNIO researchers discover new specific marker for cancer stem cells
Tumours are mosaics of cells that are morphologically and molecularly very different. In this cellular heterogeneity, it is calculated that only 1-2% of the tumour mass is made up of cancer stem cells, which over the past years have been suggested to be responsible for the origin of cancer and for the resistance to conventional chemical therapies.
CRS-207 and chemotherapy combination Phase 1b trial data for unresectable MPM presented at ASCO 2014
Aduro BioTech, Inc., a clinical stage biotechnology company, today announced the presentation of safety and efficacy data from a Phase 1b clinical trial of its novel immunotherapy CRS-207 in combination with standard chemotherapy in patients with unresectable malignant pleural mesothelioma.
XLR paediatric-optimized MRI workflow to address unmet need in imaging
HTX announced today it provided $475,385 in financing to XLR lmaging Inc. through their Technology Acceleration Program. The company is developing a complete paediatric-optimized MRI workflow solution designed to directly address the unique challenges in paediatric imaging while developing high resolution images and reducing scan times.
Dyadic signs non-binding term sheet with EnGen Bio for potential outlicense of C1 platform technology
Dyadic International, Inc., a leading biotechnology company focused on the development and manufacture of bioproducts based on its cutting-edge C1 technology to address the needs of multi-billion dollar markets for biofuels, biotherapeutics and industrial enzymes, announced today that it has signed a non-binding term sheet with EnGen Bio, Inc. for a potential outlicense, on an exclusive worldwide basis, of Dyadic's C1 platform technology for applications in biopharmaceutical drug development.
› Verified 6 days ago